Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sleep Apnea, Obstructive 1 Lymphoma, Follicular 1

Interventions

Rituximab 55 Cyclophosphamide 45 Vincristine 23 fludarabine phosphate 21 Cytarabine 20 fludarabine 19 Etoposide 19 Prednisone 18 Bendamustine Hydrochloride 18 ibrutinib 17 Methotrexate 17 Doxorubicin 17 Lenalidomide 15 Radiotherapy 14 Peripheral Blood Stem Cell Transplantation 13 Filgrastim 12 venetoclax 11 Melphalan 11 Dexamethasone 11 Whole-Body Irradiation 8 Tacrolimus 8 Busulfan 8 Brentuximab Vedotin 8 Biopsy 8 pembrolizumab 7 duvelisib 7 Nivolumab 7 Mycophenolic Acid 7 Gemcitabine 7 Cyclosporine 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Mometasone Furoate × Lymphoid × Clear all

NCT01671852 2015-07-30

Nasonex OSA

Children's & Women's Health Centre of British Columbia

Phase 3 Withdrawn

Lymphoma, Follicular, Sleep Apnea, Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡